Stock Mountie

Sunpeaks Ventures Signs Advertising Agreement for Clotamin with CBS Radio WFAN 660AM

Sunpeaks Ventures, Inc. (SNPK.OB)

SILVER SPRING, Md., April 27, 2012 /PRNewswire/ — Sunpeaks Ventures, Inc. (SNPK.OB) (SNPK.OB) (the “Company” or “Sunpeaks Ventures”) and its wholly owned subsidiary Healthcare Distribution Specialists, LLC (“HDS”) are pleased to announce that HDS has entered into an advertising agreement (the “Agreement”) with CBS Radio d/b/a WFAN 660AM (“CBS Radio”) for the marketing of Clotamin through a series of live and recorded commercials, online ads, sponsored events, and onsite retail promotions.

New York City based WFAN 660AM is considered a pioneer of the sports radio format and has been home to some of the biggest celebrity names in radio. Under terms of the Agreement, HDS has engaged CBS Radio to provide various elements for the marketing and promotion of Clotamin, including various 30 and 60 second Live Read and recorded advertisements by WFAN radio personalities Joe Benigno and legendary NFL quarterback Boomer Esiason.  Clotamin will also be mentioned as a sponsor of the popular 20/20 sports updates.  In total, 120 Live Read and 45 recorded Clotamin advertisements are expected to be aired over the 3 week duration of the contract period beginning May 28th, 2012.

CBS Radio will also provide HDS and Clotamin with prominent advertising elements at related WFAN and CBS New York online properties, Fan Van retailer locations, and sponsorship benefits at various events and broadcasts, including Breakfast with Champions featuring Mets Manager Terry Collins, Breakfast with Champions featuring Yankees Manager Joe Girardi, and two popular Yankees/Mets Subway Series Broadcasts scheduled for June.

“Expanding Clotamin distribution in and around the New York City area is a significant milestone and challenging opportunity for the Company.  With the help of WFAN 660AM, we expect to reach an enormous audience of loyal and engaged listeners with compelling ads that highlight the benefits of adding Clotamin to their daily diet,” stated Mackie A. Barch, CEO of Sunpeaks Ventures.  “New Yorkers are passionate of about their Yankees and Mets baseball.  WFAN 660AM radio is near the heart of this passion.  I can’t think of any better media outlet to help introduce Clotamin to the greatest city in the world.”

About Sunpeaks Ventures, Inc.

Sunpeaks Ventures, Inc. and its wholly owned subsidiary Healthcare Distribution Specialists, LLC (“HDS”), is a nationally focused, value-added distributor of specialty drugs and over-the-counter (“OTC”) branded multivitamins to the healthcare provider market.  HDS also owns and markets Clotamin®, a specialized over-the-counter multivitamin product designed exclusively for use by patients also on Warfarin®, a popular blood thinner that has a long list of known adverse drug and food interactions.

For additional information, please visit www.sunpeaksventures.com.

Contact: Financial Insights 888-248-8491 begin_of_the_skype_highlighting            888-248-8491     end_of_the_skype_highlighting or info@sunpeaksventures.com

Safe Harbor Statement

Information in this document constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  The words “forecast”, “anticipate”, “estimate”, “project”, “intend”, “expect”, “should”, “believe”, and similar expressions are intended to identify forward-looking statements.  These forward-looking statements involve, and are subject to known and unknown risks, uncertainties and other factors which could cause Sunpeaks Ventures’ actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements.  The risks, uncertainties and other factors are more fully discussed in Sunpeaks Ventures’ filings with the U.S. Securities and Exchange Commission.  All forward-looking statements attributable to Sunpeaks Ventures herein are expressly qualified in their entirety by the above-mentioned cautionary statement.  Sunpeaks Ventures disclaims any obligation to update forward-looking statements contained in this estimate, except as may be required by law.

Vimicro and Samsung Form Strategic Partnership to Develop Products for the China Security Surveillance Market

Vimicro International Corp. (VIMC)

BEIJING, April 27, 2012 /PRNewswire-Asia-FirstCall/ — Vimicro International Corporation (VIMC) (“Vimicro” or the “Company”), a leading multimedia semiconductor and IP-based surveillance solution provider, today announced the signing of a strategic cooperative agreement (the “Agreement”) with Tianjin Samsung Techwin Opto-Electronic Co., Ltd. outlining broad-based cooperation in the areas of technology, products, and business development. Tianjin Samsung Techwin Opto-Electronics Co., Ltd. (“Samsung”) is a joint venture that was founded by Samsung Techwin Co., Ltd. and Tianjin Zhonghuan Electronic Information Group in 2008.

(Logo: http://photos.prnewswire.com/prnh/20070528/CNM014LOGO)

Through this strategic partnership, Vimicro and Samsung will engage in comprehensive cooperation, collaborating both domestically and internationally on technology, products, and business practices, as well as jointly developing products for the China security surveillance market. For example, the companies will jointly focus on improving sales of Samsung’s front-end surveillance equipment and Vimicro’s ViSS large-scale video surveillance platform and NVR bulk-storage network video storage and management platform.

According to the Agreement, Samsung and Vimicro will improve the compatibility of their respective existing network-based surveillance products and jointly develop new functions with broader compatibility. In terms of technology and product development, Samsung will primarily focus on front-end surveillance equipment and Vimicro will primarily focus on security surveillance system platform development.

“We are pleased to have established this important strategic partnership with Samsung,” said Mr. Jiaowei (Kevin) Jin, Vimicro’s President and Chief Operating Officer. “By leveraging Samsung’s world-class technology and R&D capabilities along with our domestic leading market position, we look forward to developing even more-advanced security surveillance products and integrated solutions for our industry clients, as well as expanding the Chinese security surveillance market.”

About Tianjin Samsung Techwin Opto-Electronics Co., Ltd

Tianjin Samsung Techwin Opto-Electronics Co., Ltd. was jointly founded by Samsung Techwin Co., Ltd. and Tianjin Zhonghuan Electronic Information Group in 2008 with a total investment of $25 million and registered capital of $10 million. The company is affiliated to Samsung of South Korea and specializes in the production and sale of diverse optoelectronics and digital products, e.g. closed-circuit television (CCTV), mobile phone cameras, video presenters, digital cameras, etc. The company, on the basis of its advanced optical and digital imaging technologies, continues to develop and produce a wide range of high-quality security monitoring products, which are widely used in public security organizations, government departments, financial institutions, etc.

About Vimicro International Corporation

Vimicro International Corporation is a leading multimedia semiconductor and solution provider that designs, develops and markets mixed-signal semiconductor products and system-level solutions that enable multimedia capabilities in a variety of products for PC/Notebook, consumer electronics and surveillance markets. Vimicro is aggressively expanding business into the surveillance market with system-level solutions and semiconductor products to capitalize on China’s domestic demand. Vimicro’s ADSs, each of which represents four ordinary shares, are currently trading on the NASDAQ Global Market under the ticker symbol “VIMC.”

Breaking News ! Kenai Resources Ltd.: Purchase of 100% of Gold Aura do Brasil Mineracao Ltda

Mountie’s Bounce Play

RED EAGLE MINING CORP

While a lot of investors are placing their money in bonds and more conventional stocks that have been doing well as of late, I’ve been searching for that undervalued stock that has potential and it looks like i found it. After tracking RD.V over 2 months ago, on 3/29/2012, it started a downtrend that i believe is at it’s bottom at it’s current level of 0.38 which also happens to be the 52 week low for a possible bounce. The trend is currently strong bearish, which is getting stronger. Furthermore, the ADX indicator location between DMI+ and DMI- is hinting on a strong move ahead. Definately worth placing a strong watch on this stock for positive movement.

Profile:

Red Eagle Mining (TSX-V:RD) is a well financed gold exploration and development company with two flagship gold properties in Colombia and an experienced exploration and management team.

Key Developments:

Mining at the Santa Rosa project pre-dates the 16th century. Red Eagle has delineated over 60 historic sluice workings and over 280 adits and shafts which have been mined more recently. A 12,000 metre core drill program was completed in Q1 2012 at Santa Rosa with mineralised intercepts averaging 1.21 g/t Au. A 4,000 metre second phase resource definition program and a preliminary metallurgical program have recently commenced. The expansive Pavo Real project has numerous target types including porphyrys, skarns, broad quartz vein and veinlet systems in sedimentary host rocks, mineralized rhyodacite dykes and hydrothermal breccias. An ongoing core drill program is underway at Pavo Real

RED EAGLE Recently announced on April 17, 2012 that successful first round of drilling from its Santa Rosa gold project. reporting 1,800m strike length, weighted average grade of 1.21 g/t Au and an average width of 19m) a second, 4,000m delineation and extension drilling program has commenced on the San Ramon prospect. An initial 43-101 resource is targeted to be completed during 2012.

Ian Slater, Chief Executive Officer-”We have commenced metallurgical testing and delineation drilling in order to fast track development of the project.”

Additional 4,000m of core drilling with two rigs has commenced to complete resource definition and test extensions of the mineralisation.

The mineralised system also contains high grade, gold bearing, veins ( January 17, 2012 , reporting up to 1m at 57.30 g/t Au). These high grade veins will be evaluated with the potential for combination open pit (to 200 m) and underground mining scenarios.

In a recent article on The Gold Report April 1, 2012.  ( Gold blossoming in Colombia: Paul Harris ) A wave of companies is also coming through and exciting people’s interest by advancing very rapidly. For example  Red Eagle Mining Corp. (RD:TSX.V) listed about a year ago and have advanced to drilling and reporting drill results within a year.

Also check out Newscast for Red Eagle Mining (TSX.V – RD)  – http://vimeo.com/40678149

Quantum’s Schneider Power Subsidiary Acquires 10 MW Wind Farm in Ontario

Quantum’s Schneider Power Subsidiary Acquires 10 MW Wind Farm in Ontario – Targeted to Produce $60 Million in Revenues Over 20 Years

IRVINE, Calif., April 25, 2012 /PRNewswire/ — Quantum Fuel Systems Technologies Worldwide, Inc. (QTWW) today announced that its wholly-owned subsidiary, Schneider Power Inc. (“Schneider”), a leading developer and owner of renewable energy power plants, backed by the Schneider family’s 120 years of experience in renewable energy has acquired a newly constructed 10 megawatt utility-scale wind farm in Ontario, Canada.

The Zephyr wind farm (“Zephyr”) generation facility will supply electricity to the Ontario Power Authority under a 20-year renewable energy purchase contract, generating in excess of $3 million in estimated annual revenues. The project commenced power generation testing at 25% capacity on April 20th 2012, and is projected  to go into full production on or about May 5th, producing more than 26.7 Giga watt-hours of clean electricity per year, enough to meet the needs of 3,000 Canadian households. The project is financed by Samsung Heavy Industries of Korea.

“This acquisition is part of our long-term strategy to evolve into a leading independent power producer in North America,” said Alan P. Niedzwiecki, the President and CEO of Quantum. “We seek to increase our revenues and nameplate capacity under 100% ownership, leveraging our experience in the fast-track development of profitable renewable energy projects.”

“We are pleased and honored to be working with Samsung for financing this project,” said Thomas Schneider, the President of Schneider Power.  “Quantum and Schneider Power are active in several renewable energy projects in various stages of development, and we are actively pursuing additional opportunities in Ontario with its attractive feed in tariff programs.”

The Zephyr wind farm, located in the Brooke-Alvinston Township in the Canadian province of Ontario,will be operated by Zephyr Farms Limited, a wholly-owned subsidiary of Schneider Power. The project utilizes high efficiency, 2.5 megawatt capacity Samsung wind turbines.

About Quantum

Quantum Fuel Systems Technologies Worldwide, Inc., a fully integrated alternative energy company, is a leader in the development and production of advanced propulsion systems, energy storage technologies, and alternative fuel vehicles. Quantum’s wholly owned subsidiary, Schneider Power Inc., and affiliate Asola Solarpower GmbH complement Quantum’s emerging renewable energy presence through the development and ownership of wind and solar farms, and manufacture of high efficiency solar modules. Quantum’s portfolio of technologies includes electronic controls, hybrid electric drive systems, natural gas and hydrogen storage and metering systems and alternative fuel technologies that enable fuel efficient, low emission hybrid, plug-in hybrid electric, fuel cell, and natural gas vehicles. Quantum’s powertrain engineering, system integration, vehicle manufacturing, and assembly capabilities provide fast-to-market solutions to support the production of hybrid and plug-in hybrid, hydrogen-powered hybrid, fuel cell, natural gas fuel, and specialty vehicles, as well as modular, transportable hydrogen refueling stations. Quantum’s customer base includes automotive OEMs, dealer networks, fleets, aerospace industry, military and other government entities, and other strategic alliance partners.

Forward Looking Statements:

This press release contains forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  All statements included in this report, other than those that are historical, are forward-looking statements and can generally be identified by words such as “may,” “could,” “will,” “should,” “assume,” “expect,” “anticipate,” “plan,” “intend,” “believe,” “predict,” “estimate,” “forecast,” “outlook,” “potential,” or “continue,” or the negative of these terms, and other comparable terminology.  Various risks and other factors could cause actual results, and actual events that occur, to differ materially from those contemplated by the forward looking statements. The risk factors include changes, adjustments or corrections made to the assumptions used in determining the estimated annual revenues that the Zephyr wind farm will generate, changes in Ontario’s feed-in tariff program, Schneider Power’s and Zephyr Farms’ ability to operate and maintain  the Zephyr wind farm, Zephyr Farms’ ability to perform its obligations under the OPA power purchase agreement and to generate and supply electricity to the OPA in accordance with  the terms of the supply contract, the OPA’s ability to purchase and pay for the electricity generated by the wind farm, Schneider Power’s and Zephyr Farms’ ability to repay the Samsung construction loan, continued trouble-free service of the wind turbines and stability of the wind regime. The Company undertakes no obligation to update the information in this press release to reflect events or circumstances after the date hereof or to reflect the occurrence of anticipated or unanticipated events.

More information can be found about the products and services of Quantum and Schneider Power at http://www.qtww.com/ or you may contact:

©2012 Quantum Fuel Systems Technologies Worldwide, Inc. Advanced Technology Center 17872 Cartwright Road, Irvine, CA 92614 Phone 949-399-4500 begin_of_the_skype_highlighting            949-399-4500     end_of_the_skype_highlighting  Fax 949-399-4600

Prosperity Goldfields Corp. and Smash Minerals Announce Completion of Amalgamation

Keryx Biopharmaceuticals Inc. (KERX) Announces Positive Top-Line Results from Phase 3 Study of Ferric Citrate

Keryx Biopharmaceuticals Inc. (KERX) Announces Positive Top-Line Results from Phase 3 Study of Ferric Citrate (Zerenex™) in Japan by Partner, Japan Tobacco and Torii Pharmaceutical

NEW YORK, April 23, 2012 /PRNewswire/ — Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX – News), announced today that its Japanese partner, Japan Tobacco Inc. (JT) and Torii Pharmaceutical Co., Ltd. (Torii), has announced positive top-line results from a Phase 3 study of ferric citrate in Japan for the treatment of hyperphosphatemia in end-stage renal disease patients on hemodialysis.  This study is part of an ongoing Phase 3 program for ferric citrate in Japan for the treatment of hyperphosphatemia.

The Phase 3 study, conducted in Japan, was an open-label, randomized study evaluating the efficacy and safety of ferric citrate against an active control, sevelamer hydrochloride, over 12 weeks in hemodialysis patients with hyperphosphatemia.  In the top-line results, which evaluated the change of serum phosphorus from baseline, the primary endpoint of efficacy met non-inferiority to sevelamer hydrochloride.  Furthermore, there were no clinically significant findings on safety and tolerability of ferric citrate within the treatment period.

JT/Torii stated that it is aiming to submit the marketing application for ferric citrate in Japan in the fiscal year ending March 31, 2013.

Ron Bentsur, Chief Executive Officer of Keryx, said, “We congratulate our partner, JT/Torii, on their successful Phase 3 study and we are excited by their progress.  We are also encouraged about our partner’s plans to file their marketing application in Japan within less than a year, similar to our expected timelines for the U.S. NDA and European MAA filings.” Mr. Bentsur added, “We are enthusiastic about Zerenex’s potential differentiated product profile and its prospects for becoming an important part of the treatment of hyperphosphatemia in dialysis patients worldwide.”

Zerenex™ (ferric citrate), a ferric iron-based phosphate binder, is also in a Phase 3 clinical program in the United States for the treatment of hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal disease on dialysis, which is being conducted pursuant to a Special Protocol Assessment agreement with the FDA.

Keryx holds a worldwide license (except for certain Asian Pacific countries) to Zerenex from Panion & BF Biotech, Inc.

Sublicense Agreement with Japan Tobacco & Torii Pharmaceutical

In September 2007, Keryx sublicensed to JT/Torii the exclusive rights for the development and commercialization of its hyperphosphatemia drug, Zerenex (ferric citrate), in Japan. The licensing arrangement calls for JT/Torii to pay to Keryx up to $100 million in up-front license fees and payments upon the achievement of specified milestones, of which $28 million has been received by Keryx to date.  In addition, upon commercialization, JT/Torii will make royalty payments to Keryx on net sales of the drug in Japan. JT/Torii are responsible for all development and commercialization costs in Japan.

About Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of renal disease and cancer. Keryx is developing Zerenex (ferric citrate), an oral, ferric iron-based compound that has the capacity to bind to phosphate and form non-absorbable complexes. The Phase 3 clinical program of Zerenex for the treatment of hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal disease is being conducted pursuant to a Special Protocol Assessment (SPA) agreement with the FDA.  Keryx is also developing KRX-0401 (perifosine), which is in Phase 3 clinical development for multiple myeloma. Keryx is headquartered in New York City.

Cautionary Statement

Some of the statements included in this press release, particularly those anticipating future clinical trials and business prospects for Zerenex™ (ferric citrate) may be forward-looking statements that involve a number of risks and uncertainties. For those statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. Among the factors that could cause our actual results to differ materially are the following: our ability, and our Japanese partner’s ability, to successfully and cost-effectively complete clinical trials for Zerenex (ferric citrate); the risk that the data (both safety and efficacy) from the ongoing Phase 3 trials will not coincide with the data analyses from previous clinical trials reported by the Company; our ability to meet anticipated development timelines for Zerenex due to clinical trial results, manufacturing capabilities or other factors; if we determine that all trials of KRX-0401 (perifosine) should be terminated, our ability to successfully adjust our strategy and reduce our operating expenses relating to KRX-0401 clinical trials in order to properly support the trials of Zerenex; and other risk factors identified from time to time in our reports filed with the Securities and Exchange Commission. Any forward-looking statements set forth in this press release speak only as of the date of this press release. We do not undertake to update any of these forward-looking statements to reflect events or circumstances that occur after the date hereof. This press release and prior releases are available at http://www.keryx.com. The information found on our website is not incorporated by reference into this press release and is included for reference purposes only.

Stornoway Diamond Corporation (SWY) Closes Private Placement of Units

RepliCel ( REPCF ) Announces Closing of Private Placement

News After The Close Today 4/18/2012

RepliCel Announces Closing of Private Placement

VANCOUVER, BRITISH COLUMBIA–(Marketwire – April 18, 2012) -

NOT FOR DISSEMINATION IN THE UNITED STATES

RepliCel Life Sciences Inc. (the “Company” or “RepliCel”) (OTCBB:REPCF) is pleased to announce the closing of a private placement financing (the “Financing”), pursuant to which it has issued 502,667 units at a price of US$1.50 per unit for gross proceeds of US$754,001.

Each unit issued consisted of one common share of the Company and one common share purchase warrant. Each warrant entitles the holder to purchase an additional common share at US$2.50 per share for a period of 24 months from the closing of the Financing. An initial tranche of 66,304 Units for gross proceeds of US$99,456 closed on February 29, 2012, and a second tranche of 876,042 Units for gross proceeds of US$1,314,063 closed on March 29, 2012.

All securities issued in connection with the Financing are subject to a hold period in accordance with applicable Canadian and United States securities laws. Proceeds of the Financing will be used for general working capital requirements.

None of the securities sold in the Financing and none of the options granted, or the securities underlying the options, have been or will be registered under the United States Securities Act of 1933, as amended (the “Act”), and none of them may be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Act.

On Behalf of the Board of Directors,

Peter Jensen, Chairman of the Board

Charts Are showing Positive Signs

RSI on the rise and Bullish

Trading at 200 Day Simple Moving Avg @ 2.35

or further information, please visit their website at http://www.replicel.com.

USA Technologies’ Customer, Pepi Food Systems, Accelerates to 100% Cashless Systems in 2012

USA Technologies Inc. (USAT)

MALVERN, Pa.–(BUSINESS WIRE)–

USA       Technologies, Inc. (NASDAQ: USAT – News), (“USAT”), a leader of wireless,       cashless payment and M2M telemetry solutions for self-serve,       small-ticket retailing industries, today announced that its customer,       Pepi Food Services (“Pepi”), has signed an agreement to go 100 percent       cashless by the end of 2012. Using USA Technologies ePort Connect®       cashless payment and telemetry service, Pepi plans to convert its entire       vending machine base to 100 percent cashless three years ahead of Pepi’s       original plan.

Pepi       Food Services, based out of Dothan, Alabama, is a leader in the       vending and food services arena. Two years ago, Pepi began working on a       plan to roll out a cashless solution to its vending machine base over       the course of a five-year period. Based on outstanding customer response       to the machines already networked and incentives such as USA       Technologies’ JumpStart program, Pepi has implemented plans to       accelerate that timetable, with full deployment targeted for the end of       2012.

“Our decision to go cashless was really about the customer experience,”       said Vic Pemberton, President and founder of Pepi Food Services. “We’ve       had such a great customer response to the cashless experience on our       vending machines that we decided to speed up the implementation. We knew       we were going 100 percent cashless eventually—that was always our       vision—and with USA Technologies’ JumpStart program, there was really no       reason to wait. We like to say we’re doing it because we have to “feed       the kids” –that kids today—even my own—just aren’t carrying cash. In       fact, we’re noticing that many more of our customers now get their       paychecks on a debit card. At Pepi, we want our customers to be able to       buy with whatever is in their pocket.”

Pepi’s decision to accelerate cashless with USA Technologies was based,       in part, on the ease of USA Technologies’ “end-to-end” solution,       including USAT’s integrated telemetry services that provides customers       with cashless payment and remote data collection. Pepi has also       benefited from USA Technologies’ innovative JumpStart       program—a bundled option that enables customers to quickly deploy       the ePort cashless payment and telemetry service without upfront capital       costs.

Pemberton added, “USA Technologies’ one-stop shop makes it easy for us       to scale quickly over a short amount of time because we don’t have to       worry about piecing together a system and managing many suppliers. It’s       simple: we install the ePort®, and it works.

“Also, we are always on the lookout for the latest trends and       technologies and USA Technologies helps us stay ahead of the curve. For       example, we have already deployed some of their NFC/contactless and       mobile payments technology. When that trend reaches mainstream vending,       we want to be ready,” concluded Pemberton.

USA Technologies now has nearly 60,000 terminals linked to its ePort       Connect service that are able to accept NFC/contactless payments—RFID       and mobile—enabling its operator customers to accept these new forms of       payment. The service is designed to be open to all mobile payment       platforms, including Google Wallet, ISIS, PayPal and others.

“We are thrilled to support Pepi Food Services in this accelerated, 100       percent cashless conversion plan,” said Stephen P. Herbert, Chairman and       Chief Executive Officer of USA Technologies. “The team at Pepi has long       recognized the value of offering cashless payment systems to their       customers and they have been a big proponent of integrating technology       and innovation into their operations. We look forward to a seamless       transition and an ongoing, strategic relationship.”

Operators interested in the ePort cashless payment and telemetry system       can visit USA Technologies online at www.usatech.com       or call at 800-633-0340 begin_of_the_skype_highlighting            800-633-0340     end_of_the_skype_highlighting.

About USA Technologies:

USA Technologies is a leader in the networking of wireless non-cash       transactions, associated financial/network services and energy       management. USA Technologies provides networked credit card and other       non-cash systems in the vending, commercial laundry, hospitality and       digital imaging industries. The Company has been granted 79 patents and       has agreements with Verizon, Visa, Compass, Crane and others. Visit our       website at www.usatech.com.

About Pepi Food Services

Pepi Food Services, headquartered in Dothan, Alabama with branches in       Bainbridge, Georgia, and Tallahassee, Florida, has been a leader in       vending and food services for nearly 27 years and coffee and water       services for over 20 and 13 years, respectively. The company is a local       Canteen franchise employing 100 loyal and dedicated professionals who       deliver vending, canteen services and coffee services to over 1,000       clients. To learn more, please visit www.pepifoods.com.

Forward-looking Statements:

“Safe Harbor” Statement under the Private Securities Litigation Reform       Act of 1995: All statements other than statements of historical fact       included in this release, including without limitation the financial       position, achieving profitability, business strategy and the plans and       objectives of USAT’s management for future operations, are       forward-looking statements. When used in this release, words such as       “anticipate”, “believe”, “estimate”, “expect”, “intend”, and similar       expressions, as they relate to USAT or its management, identify       forward-looking statements. Such forward-looking statements are based on       the beliefs of USAT’s management, as well as assumptions made by and       information currently available to the USAT’s management. Actual results       could differ materially from those contemplated by the forward-looking       statements as a result of certain factors, including but not limited to,       the ability of USAT to generate sufficient sales to generate operating       profits, or conduct operations at a profit; the ability of USAT to       retain key customers from whom a significant portion of its revenues is       derived; whether USAT’s customers continue to operate or commence       operating ePorts received under the Jumpstart program or otherwise at       levels currently anticipated by USAT; the ability of USAT to compete       with its competitors to obtain market share; whether USAT’s customers       continue to utilize USAT’s transaction processing and related services,       as our customer agreements are generally cancelable by the customer on       thirty to sixty days’ notice; whether the significant increase in the       interchange fees to be charged by Visa and MasterCard for small ticket       debit card transactions would adversely affect our business, including       our revenues, gross profits, and anticipated future connections to our       network; whether or not accepting any MasterCard debit cards effective       mid-November 2011 would adversely affect our business, including our       revenues, gross profits, and anticipated future connections to our       network; and, whether USAT’s existing or anticipated customers purchase       ePort devices in the future at levels currently anticipated by USAT.       Readers are cautioned not to place undue reliance on these       forward-looking statements. Any forward-looking statement made by us in       this release speaks only as of the date of this release. Unless required       by law, USAT does not undertake to release publicly any revisions to       these forward-looking statements to reflect future events or       circumstances or to reflect the occurrence of unanticipated events.